Healthcare -
Biotechnology - NASDAQ - US
$ 3.485
1.01 %
$ 660 M
Market Cap
-8.1
P/E
ABUS - TOTAL ASSETS
Total Assets ABUS - Arbutus Biopharma Corporation
144 M
LAST VALUE
-15.97%
2 YEAR CAGR
-8.72%
5 YEAR CAGR
7.25%
10 YEAR CAGR